Time‐trends and age and stage differences in 5‐year relative survival for common cancer types by sex in the canton of Zurich, Switzerland
Cancer Medicine · 2023
DOI: 10.1002/cam4.6392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Miriam Wanner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Neoplasms, Melanoma, Skin Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Survival trends help to evaluate the progress made to reduce the burden of cancer. The aim was to estimate the trends in 5‐year relative survival of patients diagnosed with breast, prostate, lung, colorectal cancer and skin melanoma in the time periods 1980–1989, 1990–1999, 2000–2009 and 2010–2015 in the Canton of Zurich, Switzerland. Furthermore, we investigated relative survival differences by TNM stage and age group.
Methods
Data from the Cancer Registry of Zurich was used from 1980 to and including 2015, including incident cases of breast ( N = 26,060), prostate ( N = 23,858), colorectal ( N = 19,305), lung cancer ( N = 16,858) and skin melanoma ( N = 9780) with follow‐up until 31 December 2020. The cohort approach was used to estimate 5‐year relative survival.
Results
The 5‐year relative survival increased significantly between 1980 and 1989, and 2010 and2015: from 0.70 to 0.89 for breast, from 0.60 to 0.92 for prostate, from 0.09 to 0.23 (men) and from 0.10 to 0.27 (women) for lung, from 0.46 to 0.66 (men) and from 0.48 to 0.68 (women) for colorectal cancer, and from 0.74 to 0.94 (men) and from 0.86 to 0.96 (women) for skin melanoma. Survival for stage IV tumors was considerably lower compared to lower‐staged tumors for all cancer types. Furthermore, relative survival was similar for the age groups
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- European Food Safety Authority, Parma, Italy.
ORCID-Profile: Nena Karavasiloglou, Sabine Rohrmann
Zitieren
APA
Wanner, M., Syleouni, M. E., Karavasiloglou, N., Limam, M., Bastiaannet, E., Korol, D., & Rohrmann, S. (2023). Time‐trends and age and stage differences in 5‐year relative survival for common cancer types by sex in the canton of Zurich, Switzerland. Cancer Medicine. https://doi.org/10.1002/cam4.6392
Vancouver
Wanner M, Syleouni ME, Karavasiloglou N, Limam M, Bastiaannet E, Korol D, et al. Time‐trends and age and stage differences in 5‐year relative survival for common cancer types by sex in the canton of Zurich, Switzerland. Cancer Medicine. 2023. doi:10.1002/cam4.6392
BibTeX
@article{Wanner2023,
author = {Wanner, Miriam and Syleouni, Maria-Eleni and Karavasiloglou, Nena and Limam, Manuela and Bastiaannet, Esther and Korol, Dimitri and Rohrmann, Sabine},
title = {Time‐trends and age and stage differences in 5‐year relative survival for common cancer types by sex in the canton of Zurich, Switzerland},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6392}
}
EUVIMED